Squarepoint Ops LLC Moleculin Biotech, Inc. Transaction History

Squarepoint Ops LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.54 - $0.95 $28,780 - $50,633	53,298 Added 222.63%	77,238 $44,000
Q1 2023 May 15, 2023	BUY	$0.9 - $1.34 $21,546 - $32,079	23,940 New	23,940 $22,000
Q2 2021 Aug 16, 2021	SELL	$3.21 - $4.06 $92,781 - $117,350	-28,904 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.7 - $6.42 $106,944 - $185,563	28,904 New	28,904 $118,000

3.35K

Ticker MBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,606,700
Market Cap $67.5M
Description
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.